Trial Information
Molecular Markers of Prognosis in Colorectal Cancer Patients
Inclusion Criteria:
- All patients participating in the RMHNHST study of infusional versus bolus 5FU (Saini
et al. 2003).
Type of Study:
Observational
Study Design:
Time Perspective: Prospective
Principal Investigator
David Cunningham
Investigator Role:
Principal Investigator
Investigator Affiliation:
Royal Marsden NHS Foundation Trust
Authority:
United Kingdom: Medicines and Healthcare Products Regulatory Agency
Study ID:
2348
NCT ID:
NCT00220142
Start Date:
November 2003
Completion Date:
Related Keywords:
- Colorectal Cancer
- Colorectal Neoplasms
